O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WNYC’s Radiolab and Scientific American, and her ...
Chris Klomp, a top official at the federal health department, offered a reality check on President Trump’s drug discount platform, TrumpRx, while speaking at a STAT event on Thursday.
Diabetes patients taking an investigational drug from Eli Lilly saw significant reductions in their blood sugar and weight in ...
A nationwide STAT survey of NIH-funded researchers reveals that, a year after Donald Trump's return to the White House, many ...
Diabetes patients taking an investigational drug from Eli Lilly saw significant reductions in their blood sugar and weight in ...
Plus: A biotech turns to wearables and a drug giant beefs up on AI chips.
On Thursday, a dozen Senate Democrats proposed a framework for private health insurance with the goal of making it affordable ...
Adam Sherwat, the director of the Office of Infectious Diseases in the FDA’s Center for Drug Evaluation and Research, is ...
The closer we get to 2028, the more likely it is that the U.S. may settle for short-term solutions that do not meaningfully ...
Nursing homes misuse antipsychotic drugs for dementia patients, disguise practice as schizophrenia treatment, watchdog finds.
A high-dose version of Novo Nordisk’s injectable obesity drug Wegovy received U.S. approval, the company said Thursday, providing it with a new catalyst as it tries to claw back market share with its ...
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results